Literature DB >> 20881040

Vaccination reduces simian-human immunodeficiency virus sequence reversion through enhanced viral control.

Edwin R Manuel1, Wendy W Yeh, Harikrishnan Balachandran, Ryon H Clarke, Michelle A Lifton, Norman L Letvin.   

Abstract

It has been suggested that vaccination prior to infection may direct the mutational evolution of human immunodeficiency virus type 1 (HIV-1) to a less fit virus, resulting in an attenuated course of disease. The present study was initiated to explore whether prior immunization might prevent the reversion of the virus to the wild-type form. Mamu-A*01 monkeys were vaccinated to generate a cytotoxic T-lymphocyte response to the immunodominant Gag p11C epitope and were then challenged with a cloned pathogenic CXCR4-tropic simian-human immunodeficiency virus (SHIV) expressing a mutant Gag p11C sequence (Δp11C SHIV). The epitopic and extraepitopic compensatory mutations introduced into gag of Δp11C SHIV resulted in attenuated replicative capacity and eventual reversions to the wild-type Gag p11C sequence in naïve rhesus monkeys. However, in vaccinated rhesus monkeys, no reversions of the challenge virus were observed, an effect that may have been a consequence of significantly decreased viral replication rather than a redirection of the mutational evolution of the virus. These findings highlight the multifactorial pressures that affect the evolution of primate immunodeficiency viruses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20881040      PMCID: PMC3004339          DOI: 10.1128/JVI.01193-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  42 in total

1.  Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense.

Authors:  Ilhem Messaoudi; Jose A Guevara Patiño; Ruben Dyall; Joël LeMaoult; Janko Nikolich-Zugich
Journal:  Science       Date:  2002-11-29       Impact factor: 47.728

2.  Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef.

Authors:  D T Evans; D H O'Connor; P Jing; J L Dzuris; J Sidney; J da Silva; T M Allen; H Horton; J E Venham; R A Rudersdorf; T Vogel; C D Pauza; R E Bontrop; R DeMars; A Sette; A L Hughes; D I Watkins
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

3.  Evolution and transmission of stable CTL escape mutations in HIV infection.

Authors:  P J Goulder; C Brander; Y Tang; C Tremblay; R A Colbert; M M Addo; E S Rosenberg; T Nguyen; R Allen; A Trocha; M Altfeld; S He; M Bunce; R Funkhouser; S I Pelton; S K Burchett; K McIntosh; B T Korber; B D Walker
Journal:  Nature       Date:  2001-07-19       Impact factor: 49.962

4.  Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection.

Authors:  David H O'Connor; Todd M Allen; Thorsten U Vogel; Peicheng Jing; Ivan P DeSouza; Elizabeth Dodds; Edward J Dunphy; Cheri Melsaether; Bianca Mothé; Hiroshi Yamamoto; Helen Horton; Nancy Wilson; Austin L Hughes; David I Watkins
Journal:  Nat Med       Date:  2002-05       Impact factor: 53.440

5.  Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.

Authors:  Dan H Barouch; Jennifer Kunstman; Marcelo J Kuroda; Jörn E Schmitz; Sampa Santra; Fred W Peyerl; Georgia R Krivulka; Kristin Beaudry; Michelle A Lifton; Darci A Gorgone; David C Montefiori; Mark G Lewis; Steven M Wolinsky; Norman L Letvin
Journal:  Nature       Date:  2002-01-17       Impact factor: 49.962

6.  Dominant CD8+ T-lymphocyte responses suppress expansion of vaccine-elicited subdominant T lymphocytes in rhesus monkeys challenged with pathogenic simian-human immunodeficiency virus.

Authors:  Edwin R Manuel; Wendy W Yeh; Michael S Seaman; Kathryn Furr; Michelle A Lifton; Sandrine L Hulot; Patrick Autissier; Norman L Letvin
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

7.  A simian immunodeficiency virus nef peptide is a dominant cytotoxic T lymphocyte epitope in Indian-origin rhesus monkeys expressing the common MHC class I allele mamu-A*02.

Authors:  Michael H Newberg; Marcelo J Kuroda; William A Charini; Ayako Miura; Carol I Lord; Jörn E Schmitz; Darci A Gorgone; Michelle A Lifton; Kristine Kuus-Reichel; Norman L Letvin
Journal:  Virology       Date:  2002-09-30       Impact factor: 3.616

8.  Simian-human immunodeficiency virus escape from cytotoxic T-lymphocyte recognition at a structurally constrained epitope.

Authors:  Fred W Peyerl; Dan H Barouch; Wendy W Yeh; Heidi S Bazick; Jennifer Kunstman; Kevin J Kunstman; Steven M Wolinsky; Norman L Letvin
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

9.  Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual.

Authors:  Mark J Geels; Marion Cornelissen; Hanneke Schuitemaker; Kiersten Anderson; David Kwa; Jolanda Maas; John T Dekker; Elly Baan; Fokla Zorgdrager; Remco van den Burg; Martijn van Beelen; Vladimir V Lukashov; Tong-Ming Fu; William A Paxton; Lia van der Hoek; Sheri A Dubey; John W Shiver; Jaap Goudsmit
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

10.  Viral escape from dominant simian immunodeficiency virus epitope-specific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys.

Authors:  Dan H Barouch; Jennifer Kunstman; Jennifer Glowczwskie; Kevin J Kunstman; Michael A Egan; Fred W Peyerl; Sampa Santra; Marcelo J Kuroda; Jörn E Schmitz; Kristin Beaudry; Georgia R Krivulka; Michelle A Lifton; Darci A Gorgone; Steven M Wolinsky; Norman L Letvin
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

View more
  1 in total

1.  The double-edged sword: How evolution can make or break a live-attenuated virus vaccine.

Authors:  Kathryn A Hanley
Journal:  Evolution (N Y)       Date:  2011-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.